About Dr. Liu Jia
Dr. Liu Jia is a senior TCM oncologist at Longhua Hospital, affiliated with Shanghai University of Traditional Chinese Medicine — one of China's foremost centres for integrative cancer care and a national reference institution for the combined management of malignancy with classical Chinese medicine. She is recognised for her expertise in reducing chemotherapy-related toxicity, improving quality of life in advanced cancer patients, and integrating herbal medicine and acupuncture with conventional oncology protocols across breast cancer, lung cancer, and digestive tract malignancies. Dr. Liu's clinical philosophy holds that in advanced cancer, the goal of treatment is not only tumour control but the preservation of the patient's functional capacity and will to continue treatment — because a patient who cannot tolerate chemotherapy cannot benefit from it. Her department at Longhua Hospital has established one of Shanghai's most comprehensive integrative oncology programmes, combining individualised herbal prescription, acupuncture, nutritional support, and psychological care with conventional chemotherapy and endocrine therapy into a unified care pathway for patients with advanced and treatment-refractory malignancies.
Case Overview
Ms. Margaret Chen (pseudonym), a 58-year-old retired British teacher based in Shanghai, presented with Stage IV right breast cancer — invasive ductal carcinoma, ER-positive, PR-positive, HER-2-negative — three years after initial diagnosis, modified radical mastectomy, and eight cycles of AC-T chemotherapy. Disease had recurred one year prior with pulmonary metastases; she was receiving vinorelbine plus capecitabine chemotherapy and letrozole endocrine therapy. Severe treatment-related toxicity had developed: intractable nausea and vomiting, 8 kg weight loss over three months, profound fatigue, hand-foot syndrome with bilateral erythema, pain and desquamation, and severely disrupted sleep of 2–3 hours per night. TCM diagnosis identified Qi and Blood Deficiency with Spleen-Stomach Weakness. Dr. Liu Jia designed an integrative programme combining individualised herbal prescription (Bazhen Tang combined with Xiangsha Liujunzi Tang, modified) with acupuncture and continued Western oncology support. After two courses of treatment, nausea and vomiting resolved, appetite and weight stabilised, hand-foot syndrome cleared, sleep extended to 6–7 hours nightly, and EORTC QLQ-C30 scores improved significantly across all functional domains.
Patient Background
- Name / Nationality: Ms. Margaret Chen (pseudonym) — British; 58-year-old retired teacher based in Shanghai
- Age / Sex: 58-year-old female
- Chief Complaint: Severe chemotherapy-related toxicity with markedly reduced quality of life; seeking integrative TCM support to manage symptoms and improve treatment tolerance
- Oncology history: Right breast cancer (invasive ductal carcinoma, ER+/PR+/HER-2−) diagnosed 3 years prior; modified radical mastectomy followed by 8 cycles AC-T chemotherapy and 5 years tamoxifen. Disease recurrence with pulmonary metastases 1 year prior; commenced vinorelbine + capecitabine with letrozole substituted for tamoxifen
- Current toxicity profile: Frequent nausea and vomiting; severely reduced appetite; 8 kg weight loss over 3 months; profound fatigue with restricted daily activity; bilateral hand-foot syndrome — erythema, pain, desquamation — impairing walking and grip; sleep 2–3 hours per night with frequent waking
- Past medical history: No hypertension, diabetes, or cardiac disease; no drug allergies
-
TCM four examinations:
- Inspection: Sallow complexion; emaciated; listless; sparse, dry hair; pale, swollen tongue with tooth marks; white greasy coating
- Auscultation/olfaction: Low voice; short breath; no abnormal odour
- Inquiry: Generalised fatigue; dyspnoea on exertion; anorexia; post-prandial nausea and vomiting; abdominal distension; loose stools 2–3 times daily; hand-foot pain disrupting sleep; low mood; loss of confidence in treatment
- Palpation: Thready, weak pulse (细弱无力脉)
Diagnostic Workup
Chest CT
- Post-operative changes from right mastectomy; multiple bilateral pulmonary nodules — stable compared with prior imaging, no evidence of progression
Full Blood Count
- Haemoglobin 90 g/L; white cell count 3.0 × 10⁹/L; platelet count 100 × 10⁹/L — myelosuppression confirmed across all three lineages
Liver and Renal Function
- ALT 50 U/L; AST 45 U/L — mild hepatotoxicity; creatinine 90 μmol/L; BUN 6.0 mmol/L — renal function within acceptable limits
Dr. Liu's pre-treatment assessment: This patient is in a common and dangerous position in advanced cancer care: the tumour is stable, but the patient is deteriorating. The chemotherapy is working against the cancer, but it is also working against the patient — depleting her Qi and Blood, injuring her Spleen and Stomach, and destroying her sleep. If we do not address the toxicity, she will not be able to continue the chemotherapy, and the tumour will progress. The TCM diagnosis is clear: Qi and Blood Deficiency with Spleen-Stomach Weakness. The tongue — pale, swollen, tooth-marked, with a white greasy coating — tells us the Spleen is failing to transform and transport. The pulse — thready and weak — tells us the Blood is insufficient and the Qi is exhausted. The treatment principle must be to tonify the Qi and nourish the Blood, strengthen the Spleen and harmonise the Stomach, while the Western team continues to manage the tumour and the acute haematological toxicity. These are not competing approaches — they are addressing different aspects of the same patient.
TCM Diagnosis and Integrative Treatment Strategy
The TCM diagnosis established by Dr. Liu Jia was Breast Rock — Qi and Blood Deficiency with Spleen-Stomach Weakness (乳岩·气血两虚，脾胃虚弱证). The corresponding Western diagnoses were Stage IV right breast cancer with pulmonary metastases; chemotherapy-induced myelosuppression; nausea and vomiting; hand-foot syndrome; and sleep disorder.
The treatment principle was: tonify Qi and nourish Blood; strengthen the Spleen and harmonise the Stomach; move Blood and unblock the collaterals (益气养血，健脾和胃，活血通络).
Herbal prescription — Bazhen Tang combined with Xiangsha Liujunzi Tang, modified: Dangshen 30g, Baizhu 15g, Fuling 15g, Gancao 6g, Danggui 15g, Chuanxiong 10g, Baishao 15g, Shudi 15g, Muxiang 6g, Sharen 6g (added late), Chenpi 10g, Banxia 10g, Huangqi 30g, Jixueteng 30g. One decoction daily, taken warm in two divided doses. Rationale: Bazhen Tang (Eight Treasure Decoction) tonifies both Qi and Blood simultaneously; Xiangsha Liujunzi Tang strengthens the Spleen, harmonises the Stomach, and resolves Damp; Huangqi augments the Qi-tonifying effect and supports immune function; Jixueteng activates Blood and unblocks the collaterals to address the hand-foot syndrome.
Acupuncture — primary points: Zusanli (ST 36), Zhongwan (CV 12), Guanyuan (CV 4), Qihai (CV 6), Pishu (BL 20), Weishu (BL 21), Neiguan (PC 6), Gongsun (SP 4).
Supplementary points by symptom: Danzhong (CV 17) and Fenglong (ST 40) for severe nausea and vomiting; Hegu (LI 4), Taichong (LR 3), Bafeng (EX-LE 10), and Baxie (EX-UE 9) for hand-foot pain; Shenmen (HT 7), Sanyinjiao (SP 6), and Anmian (EX-HN 22) for sleep disorder.
Needling technique: Zusanli, Zhongwan, Guanyuan, and Qihai needled with reinforcing method, depth 1.0–1.5 cun, retained 30 minutes with manipulation every 10 minutes. Pishu and Weishu with even method, depth 0.8–1.2 cun, retained 30 minutes. Remaining points with technique selected according to symptom pattern. Bafeng and Baxie: pricking bloodletting once to twice weekly. Three sessions per week; ten sessions per course; two courses total.
Western oncology support (concurrent): Continuation of vinorelbine + capecitabine and letrozole per oncology team. Haematological support: recombinant G-CSF for leucopenia; recombinant EPO for anaemia; platelet transfusion support as required. Symptomatic management: ondansetron for nausea and vomiting; topical vitamin B6 cream for hand-foot syndrome; estazolam for sleep.
Treatment Course and Outcomes
After Course 1 (Sessions 1–10)
- Nausea and vomiting significantly reduced; appetite improved — normal meals tolerated 4–5 times per week
- Fatigue partially relieved; slow indoor ambulation possible
- Hand-foot pain reduced; basic grip and walking function restored
- Sleep extended to 4–5 hours per night with improved continuity
- Haemoglobin 100 g/L; WBC 4.0 × 10⁹/L; platelets 120 × 10⁹/L — all three lineages improved
- ALT 40 U/L; AST 40 U/L — hepatotoxicity resolved
After Course 2 (Sessions 11–20)
- Nausea and vomiting resolved; appetite fully restored; weight stable — no further loss
- Fatigue further reduced; routine household activities resumed
- Hand-foot syndrome cleared — bilateral erythema, pain, and desquamation resolved; walking and grip function normal
- Sleep 6–7 hours per night, deep and restorative
- EORTC QLQ-C30 assessment: significant improvement in physical, role, emotional, cognitive, and social functioning scores — overall quality of life markedly improved
- Patient attitude: restored confidence in treatment; active engagement with ongoing oncology programme
Dr. Liu's clinical reflection: The most important outcome in this case is not the laboratory improvement — it is that the patient is willing to continue her chemotherapy. When she first came to us, she was considering stopping treatment. The toxicity had broken her. After two courses, she is sleeping, eating, and walking. She has her life back, within the constraints of her illness. That is what integrative oncology is for — not to replace the chemotherapy, but to make it survivable. The Spleen and Stomach are the foundation of post-heaven Qi in TCM. When the Spleen is strong, the patient can eat, absorb, and generate the Blood and Qi that the body needs to withstand treatment. Strengthening the Spleen is not a soft intervention — it is the foundation on which everything else depends.
Expert Commentary — Dr. Liu Jia
1. The Rationale for Integrative TCM in Advanced Cancer: Complementarity, Not Competition
The most common misunderstanding about integrative TCM in oncology is that it represents an alternative to conventional treatment — that patients who choose acupuncture and herbal medicine are choosing not to have chemotherapy. The clinical reality is the opposite. The patients who benefit most from integrative TCM in oncology are those who are receiving the most aggressive conventional treatment and whose bodies are struggling to tolerate it. Chemotherapy-induced myelosuppression, nausea, fatigue, and neuropathy are not minor inconveniences — they are the primary reasons that patients reduce doses, delay cycles, or discontinue treatment entirely. Dose reductions and treatment delays reduce the efficacy of chemotherapy. Anything that allows a patient to maintain the planned chemotherapy dose and schedule — including TCM interventions that reduce toxicity and improve tolerance — directly supports the oncological outcome. The evidence base for specific TCM interventions in chemotherapy toxicity management is now substantial: acupuncture at Neiguan and Zusanli for chemotherapy-induced nausea and vomiting has been evaluated in multiple randomised controlled trials and is endorsed by ASCO guidelines as a complementary intervention. Herbal formulae based on Qi and Blood tonification have demonstrated measurable effects on haematopoietic recovery in myelosuppressed patients. The integration is not philosophical — it is evidence-based and outcome-driven.
2. Hand-Foot Syndrome: Why TCM Offers What Western Supportive Care Cannot
Hand-foot syndrome (palmar-plantar erythrodysaesthesia) is one of the most debilitating toxicities of capecitabine-based chemotherapy, and Western supportive care options are limited: dose reduction, topical emollients, and vitamin B6 supplementation provide partial relief but do not address the underlying pathophysiology. In TCM, hand-foot syndrome is understood as a manifestation of Blood stasis and Heat toxin accumulating in the extremities — the channels of the hands and feet become obstructed, local circulation is impaired, and the accumulated Heat produces the erythema, pain, and tissue breakdown that characterise the syndrome. The treatment principle is to activate Blood, resolve stasis, clear Heat, and unblock the collaterals of the extremities. Acupuncture at Bafeng and Baxie — the eight points between the toes and the eight points between the fingers — with pricking bloodletting directly addresses the local Blood stasis in the affected tissues. Jixueteng in the herbal formula activates Blood and unblocks the collaterals systemically. The combination of local needling and systemic herbal treatment produced complete resolution of hand-foot syndrome in this patient within twenty sessions — an outcome that topical vitamin B6 alone had not achieved over months of application.
3. Sleep, Qi, and the Oncology Patient: Why Restoring Sleep Is a Medical Priority
Sleep disruption in advanced cancer patients is almost universal and almost universally undertreated. Western oncology typically addresses it with sedative-hypnotic medication — effective for sleep initiation but associated with dependence, morning sedation, and cognitive impairment that further reduce quality of life. In TCM, chronic sleep disruption in a patient with Qi and Blood Deficiency is understood as a failure of the Heart to house the Shen — the spirit — because the Blood that anchors the Shen is insufficient. The treatment is not sedation but nourishment: tonifying the Heart Blood and calming the Shen through Shenmen, Sanyinjiao, and Anmian, combined with the systemic Blood-nourishing effect of the herbal formula. In this patient, sleep extended from 2–3 hours to 6–7 hours over twenty acupuncture sessions — without increasing the sedative medication dose. Restored sleep produced cascading benefits: improved appetite, reduced fatigue, better emotional regulation, and renewed engagement with treatment. In oncology, sleep is not a comfort measure — it is a physiological prerequisite for immune function, tissue repair, and the psychological resilience that advanced cancer demands.
How CMCS Shanghai Coordinated This Case
CMCS Shanghai supported Ms. Chen and her family from initial consultation through the completion of two treatment courses, including: priority appointment coordination with Dr. Liu Jia at Longhua Hospital with bilingual review of all prior oncology records, chemotherapy summaries, and imaging reports; bilingual interpretation throughout all TCM four-examination consultations, herbal prescription discussions, and integrative treatment planning sessions; coordination between Dr. Liu Jia's TCM team and the patient's Western oncology team to ensure the herbal prescription and acupuncture schedule were aligned with chemotherapy cycles and did not conflict with concurrent medications; bilingual pharmacy support for herbal decoction preparation instructions and daily dosing schedule; weekly symptom tracking with bilingual progress summaries communicated to the patient's oncologist in the UK; EORTC QLQ-C30 quality of life assessment coordination with bilingual results communication; and end-of-treatment comprehensive summary provided to the patient's GP and oncology team overseas for continuity of integrative care planning.
For international patients with advanced cancer seeking integrative TCM support alongside conventional oncology treatment in Shanghai, Dr. Liu Jia's team at Longhua Hospital offers a clinically rigorous, evidence-informed approach — combining individualised herbal prescription, acupuncture, and Western supportive care to reduce toxicity, restore function, and sustain the patient's capacity to complete treatment. CMCS ensures that expertise is accessible: in the patient's language, with overseas physicians informed at every step, from the first integrative consultation through long-term follow-up.
This case report is de-identified and published for educational purposes. All clinical details have been anonymized in accordance with patient privacy standards. CMCS Shanghai is a medical concierge service and does not provide direct medical care.
0 Kommentare